Hugel, Inc. (KOSDAQ:145020)

South Korea · Delayed Price · Currency is KRW

270,000

+4,500 (1.69%)

At close: Feb 27, 2026

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	425.10B	373.05B	319.70B	281.68B	231.86B
Pharmaceuticals Growth	13.95%	16.69%	13.50%	21.49%	9.87%
Total	425.10B	373.05B	319.70B	281.68B	231.86B
Total Growth	13.95%	16.69%	13.50%	21.49%	9.87%

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Korea	95.00B	147.81B	142.73B	131.27B	113.49B
Korea Growth	-35.73%	3.56%	8.73%	15.67%	-6.59%
Asia Pacific	141.10B	-	-	-	-
North & South America	67.90B	33.29B	27.54B	22.93B	13.10B
North & South America Growth	103.98%	20.89%	20.11%	75.04%	151.37%
Eu & Others	59.50B	-	-	-	-
Asia	-	118.63B	91.50B	83.00B	81.13B
Asia Growth	-	29.65%	10.24%	2.32%	21.06%
Europe and Middle East	-	58.72B	45.24B	39.87B	21.22B
Europe and Middle East Growth	-	29.79%	13.49%	87.89%	43.86%
Other	-	14.59B	12.68B	4.61B	2.93B
Other Growth	-	15.06%	175.22%	57.31%	14.10%
Discontinued Business (*)	-	-	-	10.34B	-
Total	363.50B	373.05B	319.70B	292.02B	231.86B
Total Growth	-2.56%	16.69%	9.48%	25.95%	9.87%

Source: S&P Global Market Intelligence.